Uchida, T., Kaira, K., Yamaguchi, O., Mouri, A., Shiono, A., Miura, Y., . . . Kagamu, H. (2019). Different incidence of interstitial lung disease according to different kinds of EGFR‐tyrosine kinase inhibitors administered immediately before and/or after anti‐PD‐1 antibodies in lung cancer. Thorac Cancer.
Čikaški stil citiranjaUchida, Takahiro, et al. "Different Incidence of Interstitial Lung Disease According to Different Kinds of EGFR‐tyrosine Kinase Inhibitors Administered Immediately Before And/or After Anti‐PD‐1 Antibodies in Lung Cancer." Thorac Cancer 2019.
MLA način citiranjaUchida, Takahiro, et al. "Different Incidence of Interstitial Lung Disease According to Different Kinds of EGFR‐tyrosine Kinase Inhibitors Administered Immediately Before And/or After Anti‐PD‐1 Antibodies in Lung Cancer." Thorac Cancer 2019.